Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial.

BMC Med · 2026 · PMC13041475 · PMID 41742206

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding LRR, group 4 demonstrated a trend toward reduced risk compared with group 3 (HR 0.410, 95% CI 0.174 to 0.967), although this difference did not reach statistical significance (Fig. 2 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.